Komipharm International Company Limited operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Komipharm International Company Limited with three other
pharmaceutical manufacturers in Asia:
Pharma Foods International Co.Ltd
sales of 3.46 billion Japanese Yen [US$31.15 million]
of which 60%
was Functional product(Online business)),
(2.47 billion Japanese Yen [US$22.27 million]
of which 64%
was Health Inspection Equipment), and
Choong Ang Vaccine Laboratory
(37.90 billion Korean Won [US$33.92 million]
Komipharm International Company Limited reported sales of 37.64 billion Korean Won (US$33.68 million)
December of 2016.
increase of 3.4%
versus 2015, when the company's sales were 36.41 billion Korean Won.
Sales at Komipharm International Company Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 103%).